200,000+ products from a single source!
sales@angenechem.com
120-97-8 | 1,3-Benzenedisulfonamide, 4,5-dichloro-
CAS No: 120-97-8 Catalog No: AG000Q1A MDL No:MFCD00148948
Product Description
Catalog Number:
AG000Q1A
Chemical Name:
1,3-Benzenedisulfonamide, 4,5-dichloro-
CAS Number:
120-97-8
Molecular Formula:
C6H6Cl2N2O4S2
Molecular Weight:
305.1588
MDL Number:
MFCD00148948
IUPAC Name:
4,5-dichlorobenzene-1,3-disulfonamide
InChI:
InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)
InChI Key:
GJQPMPFPNINLKP-UHFFFAOYSA-N
SMILES:
Clc1cc(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N
EC Number:
204-440-6
UNII:
VVJ6673MHY
Properties
Complexity:
452
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
303.915g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
305.144g/mol
Monoisotopic Mass:
303.915g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
137A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3
Literature
| Title | Journal |
|---|---|
| Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo. | Diabetes 20120801 |
| Sulfonamides: a patent review (2008 - 2012). | Expert opinion on therapeutic patents 20120701 |
| Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. | Journal of medicinal chemistry 20120412 |
| Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana. | Bioorganic & medicinal chemistry 20120215 |
| Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II. | Bioorganic & medicinal chemistry letters 20111001 |
| Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives. | European journal of medicinal chemistry 20110901 |
| Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. | Bioorganic & medicinal chemistry 20110815 |
| Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. | Bioorganic & medicinal chemistry 20110615 |
| Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. | Bioorganic & medicinal chemistry letters 20110601 |
| Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. | Bioorganic & medicinal chemistry letters 20110515 |
| Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. | Bioorganic & medicinal chemistry 20110515 |
| Evaluation of the reproductive and developmental risks of caffeine. | Birth defects research. Part B, Developmental and reproductive toxicology 20110401 |
| Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii. | Bioorganic & medicinal chemistry 20110315 |
| (R)-/(S)-10-camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases. | Bioorganic & medicinal chemistry letters 20110301 |
| A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. | Bioorganic & medicinal chemistry 20110201 |
| Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. | Bioorganic & medicinal chemistry letters 20110115 |
| Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. | Frontiers in pharmacology 20110101 |
| Treat ankylosing spondylitis with methazolamide. | International journal of medical sciences 20110101 |
| Skeletal muscle na channel disorders. | Frontiers in pharmacology 20110101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. | European journal of medicinal chemistry 20100901 |
| Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. | Journal of medicinal chemistry 20100812 |
| Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides. | European journal of medicinal chemistry 20100601 |
| Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. | Journal of medicinal chemistry 20100311 |
| Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. | BMC musculoskeletal disorders 20100101 |
| Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. | Bioorganic & medicinal chemistry letters 20091201 |
| Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy. | Human molecular genetics 20091101 |
| Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. | Bioorganic & medicinal chemistry 20090715 |
| Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides. | Bioorganic & medicinal chemistry 20090701 |
| Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII. | Bioorganic & medicinal chemistry letters 20090601 |
| Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. | Journal of medicinal chemistry 20090514 |
| Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. | Journal of medicinal chemistry 20090423 |
| QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. | Journal of enzyme inhibition and medicinal chemistry 20090401 |
| Biodegradable fumarate-based drug-delivery systems for ophthalmic applications. | Journal of biomedical materials research. Part A 20090315 |
| Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. | Bioorganic & medicinal chemistry 20090201 |
| Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. | Journal of medicinal chemistry 20081113 |
| Treatment of neuromuscular channelopathies: current concepts and future prospects. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20081001 |
| Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications? | Organic & biomolecular chemistry 20080721 |
| Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes. | Bioorganic & medicinal chemistry letters 20080615 |
| Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII. | Journal of medicinal chemistry 20080612 |
| Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+) -depleted rats. | British journal of pharmacology 20080501 |
| Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. | Bioorganic & medicinal chemistry letters 20080415 |
| Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. | Bioorganic & medicinal chemistry letters 20080415 |
| Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. | Bioorganic & medicinal chemistry 20080401 |
| Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. | Journal of medicinal chemistry 20080327 |
| Treatment for periodic paralysis. | The Cochrane database of systematic reviews 20080123 |
| The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. | Current pharmaceutical design 20080101 |
| Practical aspects in the management of hypokalemic periodic paralysis. | Journal of translational medicine 20080101 |
| Muscle channelopathies and electrophysiological approach. | Annals of Indian Academy of Neurology 20080101 |
| Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. | Bioorganic & medicinal chemistry 20071201 |
| Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides. | Bioorganic & medicinal chemistry letters 20070915 |
| Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies. | Bioorganic & medicinal chemistry letters 20070801 |
| Carbonic anhydrases as targets for medicinal chemistry. | Bioorganic & medicinal chemistry 20070701 |
| Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. | Bioorganic & medicinal chemistry letters 20070701 |
| Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. | Journal of medicinal chemistry 20070405 |
| Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. | Bioorganic & medicinal chemistry letters 20070315 |
| Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. | Bioorganic & medicinal chemistry letters 20070215 |
| Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. | Journal of medicinal chemistry 20070125 |
| The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents. | Current topics in medicinal chemistry 20070101 |
| Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. | Journal of medicinal chemistry 20061130 |
| A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by 'click-tailing'. | Journal of medicinal chemistry 20061102 |
| Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. | Journal of medicinal chemistry 20060907 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. | Bioorganic & medicinal chemistry letters 20060415 |
| Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. | Journal of medicinal chemistry 20060323 |
| Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib. | Bioorganic & medicinal chemistry letters 20060115 |
| Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels. | Neuromuscular disorders : NMD 20060101 |
| [Diuretic therapy in heart failure]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20060101 |
| Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. | Journal of medicinal chemistry 20051201 |
| Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides. | Bioorganic & medicinal chemistry letters 20051101 |
| Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. | Bioorganic & medicinal chemistry letters 20050901 |
| Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. | Bioorganic & medicinal chemistry letters 20050901 |
| Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation. | Therapeutic drug monitoring 20050801 |
| Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. | Journal of medicinal chemistry 20050728 |
| Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. | Bioorganic & medicinal chemistry letters 20050615 |
| Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. | Bioorganic & medicinal chemistry letters 20050615 |
| Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds. | Bioorganic & medicinal chemistry letters 20050502 |
| [Diclofenamide]. | Tijdschrift voor diergeneeskunde 20050415 |
| Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? | Bioorganic & medicinal chemistry letters 20050215 |
| Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20050215 |
| Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. | Bioorganic & medicinal chemistry letters 20050215 |
| Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. | Bioorganic & medicinal chemistry letters 20050201 |
| A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G). | Journal of Korean medical science 20050201 |
| Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. | Bioorganic & medicinal chemistry letters 20050117 |
| Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. | BMC cancer 20050101 |
| Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides. | Bioorganic & medicinal chemistry letters 20041220 |
| Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. | Bioorganic & medicinal chemistry letters 20041206 |
| Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties. | Bioorganic & medicinal chemistry letters 20041101 |
| Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. | Bioorganic & medicinal chemistry 20041015 |
| Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. | Journal of medicinal chemistry 20041007 |
| Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design. | Bioorganic & medicinal chemistry letters 20040716 |
| Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20040621 |
| Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor. | Journal of enzyme inhibition and medicinal chemistry 20040601 |
| Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity. | Journal of medicinal chemistry 20040520 |
| Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. | Bioorganic & medicinal chemistry letters 20040503 |
| Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. | Journal of medicinal chemistry 20040422 |
| Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040401 |
| Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. | Journal of medicinal chemistry 20040226 |
| Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. | Bioorganic & medicinal chemistry letters 20040223 |
| Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. | Journal of medicinal chemistry 20040129 |
| Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. | Bioorganic & medicinal chemistry letters 20040119 |
| Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. | Bioorganic & medicinal chemistry letters 20040105 |
| Generation and evaluation of a CYP2C9 heteroactivation pharmacophore. | The Journal of pharmacology and experimental therapeutics 20031201 |
| Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. | Journal of medicinal chemistry 20030522 |
| Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. | Bioorganic & medicinal chemistry letters 20030324 |
| Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives. | Bioorganic & medicinal chemistry letters 20030310 |
| Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. | Bioorganic & medicinal chemistry letters 20030310 |
| Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails. | Bioorganic & medicinal chemistry letters 20020617 |
| Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. | Journal of medicinal chemistry 20020328 |
| Long-term management of a glaucomatous eye in a dog treated with medical therapy alone. | The Journal of veterinary medical science 20011201 |
| Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. | Annals of neurology 20000101 |
| [Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences]. | Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 19910101 |
| Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors. | The British journal of ophthalmology 19680801 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.